Advertisement

Topics

PHARMA INDUSTRY FINLAND Company Profile

23:24 EDT 17th June 2018 | BioPortfolio

Pharma Industry Finland (PIF) is an association supervising the industrial policy interests of the research-based pharmaceutical industry. Through communication PIF creates a comprehensive public image of the pharmaceutical industry. PIF's aim is to develop the competitiveness as well as the research and operation environment of the industry both in Finland and the EU so that the best possible pharmaceutical treatment reaches patients without delays. This is done by influencing economic, industry and socio-policy legislation.PIF represents almost all the pharmaceutical companies researching, manufacturing and marketing medicinal products in Finland. The members represent the research-based, generic, OTC and veterinary pharmaceutical industry. Altogether PIF has 63 members.
The association helps its members and the media in all questions relating to the pharmaceutical industry. PIF takes initiatives, gives comments to the authorities on behalf of its members, carries out surveys on current topics and produces pharmaceutical statistics. PIF also organises information meetings and education for its members, and offers the general public and interest groups information about the industry.
PIF, Pharmaceutical Information Centre, The Supervisory Commission for the Marketing of Medicinal Products and The Finnish Cooperative for the Indemnification of Medicines-Related Injuries make up the pharmaceutical corporation.

Location

PO Box 109
Helsinki
FIN-00131
Finland

Contact

Phone: 358 9 6150 4900
Fax: 358 9 6510 4941
Email: firstname.lastname@pif.fi


News Articles [1157 Associated News Articles listed on BioPortfolio]

New way of producing useful compounds from birch for the cosmetics industry

(VTT Technical Research Centre of Finland) VTT Technical Research Centre of Finland has used plant cell culture technology to develop new types of ingredients for the cosmetics industry.

Mobidiag obtains $1.74M funding from Business Finland

An approximately $1.74 million loan was secured by Finland-based Mobidiag from funding agency Business Finland.  -More- 

Wheelchair Market in Finland to 2022 [Report Updated: 21022018] Prices from USD $603

The report Wheelchair Market in Finland to 2022 offers the most uptodate industry data on the actual market situation, and future outlook for wheelchairs in Finland. The research includes historical d...

Medicortex Finland Oy: Clinical Trial Launched for Detection of Traumatic Brain Injury

TURKU, Finland–(BUSINESS WIRE)–Medicortex Finland Oy today announced that the first patient has been enrolled in the Phase 2 clinical trial of ProbTBI™ diagnostic kit for Traumatic ...

Finland is world's happiest country, U.S. discontent grows: U.N. report

Finland is the world's happiest country, according to an annual survey issued on Wednesday that found Americans were getting less happy even as their country became richer. Burundi came bottom in the...

Academy of Finland Flagship funding for Aalto University and VTT to develop new biomaterials

(VTT Technical Research Centre of Finland) Aalto University and VTT Technical Research Centre of Finland Ltd. will set up a competence center for materials bioeconomy called CERES to develop new mater...

Insulin Market in Finland to 2022 Market Size, Development, and Forecasts [Report Updated: 08012018] Prices from USD $588

The industry report Insulin Market in Finland to 2022 Market Size, Development, and Forecasts offers the most uptodate market data on the actual market situation, and future outlook for insulin in Fi...

Vaccine Market in Finland to 2022 Market Size, Development, and Forecasts [Report Updated: 08012018] Prices from USD $588

The industry report Vaccine Market in Finland to 2022 Market Size, Development, and Forecasts offers the most uptodate market data on the actual market situation, and future outlook for vaccines in F...

PubMed Articles [353 Associated PubMed Articles listed on BioPortfolio]

Increase in Childhood Nontuberculous Mycobacterial Infections after BCG Coverage Drop - a Nationwide Population-Based Retrospective Study, Finland, 1995 to 2016.

Epidemiological data on childhood nontuberculous mycobacterial (NTM) disease is scarce and the protective effect of Bacillus Calmette-Guérin (BCG) vaccination remains debated. In 2006 the BCG policy ...

Finland establishing the internet of genomics and health data.

Genomic data, i.e. measurement of variation in the complete genome has revolutionized genetic research and changed our understanding of the pathogenetic mechanisms of diseases. Genomic data in combina...

A totally new system is needed for drug research and development.

In response to my paper, where I call for abolishment of patents and for drug research and development as a public enterprise, Raj asserts that there is an increase in novel drug discoveries. The fact...

How Well Are We Applying Quantitative Methods to Reverse Translation to Inform Early Clinical Development?

If we are to improve our low success rate and rising costs in the pharmaceutical industry, we need to use every tool available. Reverse translation can particularly inform discovery and early clinical...

Ion mobility in the pharmaceutical industry: an established biophysical technique or still niche?

Over the past decade ion mobility (IM) coupled with mass spectrometry (MS) has emerged as a wide spread analytical technique, utilized in research areas ranging from small molecule to proteins analyze...

Clinical Trials [266 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Prodactariv 60 mg F.C.T (International Drug Agency for Pha...

Strongest Families Finland Canada: Family-based Prevention and Treatment Program of Early Childhood Disruptive Behavior

The goal of the Strongest Families Finland Canada project is to help parents develop skills to strengthen their families and reduce disruptive behavior in their 4 year old children.

An RCT of a Smartphone-based TID Programme

The study aims to test the effect a smartphone-based intervention on primary school students and their parents' attitudes towards tobacco industry and their tobacco-related communications.

A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland

Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland.

Type 1 Diabetes Prediction and Prevention (DIPP) Study

The Type 1 Diabetes Prediction and Prevention (DIPP) Study in Finland is a population-based long-term clinical follow-up study established since 1994 in three university hospitals in Finla...

Companies [1498 Associated Companies listed on BioPortfolio]

PHARMA INDUSTRY FINLAND

Pharma Industry Finland (PIF) is an association supervising the industrial policy interests of the research-based pharmaceutical industry. Through communication PIF creates a comprehensive public imag...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

SUOMEN BIOTEOLLISUUS FINNISH BIOINDUSTRIES

Finnish Bioindustries FIB is Finland's biotechnology industry association, established in 1997. It is a private, independent non-profit organisation.Member companies represent all life science areas, ...

Abmin Technologies Limited

Abmin Technologies is based in Turku, Finland. It was founded in 1996 by Instrumentarium Corp (Helsinki, Finland), Finnish National Fund for Research and Development (SITRA) and Aboatech Ltd (Turku, F...

PCAS Finland Oy

PCAS Finland Oy has produced APIs since 1960, and it was the first company to produce active pharmaceutical ingredients in commercial quantities in Finland. Until June 2001, PCAS Finland Oy was an int...

More Information about "PHARMA INDUSTRY FINLAND" on BioPortfolio

We have published hundreds of PHARMA INDUSTRY FINLAND news stories on BioPortfolio along with dozens of PHARMA INDUSTRY FINLAND Clinical Trials and PubMed Articles about PHARMA INDUSTRY FINLAND for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PHARMA INDUSTRY FINLAND Companies in our database. You can also find out about relevant PHARMA INDUSTRY FINLAND Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...


Corporate Database Quicklinks



Searches Linking to this Company Record